116
Aojing Medical (688613.SH) issued an announcement that the company received a notification letter from BioVeda China RMB Investment Limited, a shareholder holding more than 5% of the shares, on June 30, 2022. During the period from June 30, 2022, a total of 1.591 million shares of the company were reduced through block transactions, and the number of shares reduced accounted for 1.1932% of the company’s total share capital.
Shareholder benefits are here! Top ten gold stocks for you, take you to the “golden pit” of the Nuggets! Click to view>>
Massive information, accurate interpretation, all in Sina Finance APP